RhabdomyolysisNCT07528300
Effect of Battlefield Acupuncture on Pain Control During Inpatient Treatment of Exertional Rhabdomyolysis
A study testing Battlefield Acupuncture in people with Rhabdomyolysis, run by Tripler Army Medical Center at 1 site in United States.
Trial summary
Patients admitted with exertional rhabdomyolysis will be offered treatment with battlefield acupuncture for pain management and compared with patient's pain levels and pain medication requirements with those patients who declined battlefield acupuncture. Read more about this study
- Who is it for?
- Ages 18 to 99 yearsHealthy volunteers can take part
- Conditions the study is for
- Rhabdomyolysis
- What is being tested?
- Battlefield Acupuncture
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 36 participants
- Where
- 1 siteUnited States
- Study dates
- 24 Apr 2023to 24 Apr 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 99 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Rhabdomyolysis
- chooses battlefield acupuncture
Who cannot join
- Greater than 72 hours from onset of symptoms
- younger than 18 years of age
- declines battlefield acupuncture
- no pain
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
Tripler Army Medical Center
TAMC, Hawaii, 96859
Susan A Scrivner, BS, 808-433-5486, susan.a.scrivner.ctr@health.mil
About this study
Patients admitted with exertional rhabdomyolysis will be offered treatment with battlefield acupuncture for pain management and compared with patient's pain levels and pain medication requirements with those patients who declined battlefield acupuncture.
Read the detailed description
Pilot study using a prospective observational case series of patients admitted to Tripler Army Medical Center who meet CHAMP criteria for rhabdomyolysis and who elect to undergo BFA in addition to standard of care pain control. We will not blind patients, providers, or research coordinators. Goal is to administer BFA within 12 hours of inpatient admission and monitor the pain response.
- Conditions
- Rhabdomyolysis
- Being tested
- Battlefield Acupuncture
- Keywords
- battlefield acupuncture, rhabdomyolysis, pain management
- Medical subject headings
- Rhabdomyolysis, Agnosia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Battlefield AcupunctureProcedure or surgery
Treatment of pain from rhabdomyolysis with battlefield acupuncture
| Study group | Role | What they receive |
|---|---|---|
| Battlefield Acupuncture | Active comparator | Patients admitted with rhabdomyolysis who choose to get battlefield acupuncture for pain control. Receives: Procedure: Battlefield Acupuncture |
| Patients admitted with rhabdomyolysis who did not receive battlefield acupuncture | No intervention | This arm is the retrospective group that did not receive the BFA as an intervention. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Pain Level on a pain scale of 0-10
Reported pain levels on a subjective pain score of 0-10
Measured: Pain level will be measured through study completion (up to 12 months).
Pain Medication
Amount of pain medication required, Morphine equivalent and acetaminophen use on hospital days 1-7
Measured: From enrollment to the end of treatment at 12 months
Secondary outcomes (1)
Length of Hospital Stay in days
How long the patient stays in the hospital in days
Measured: Length of time from admission to discharge in days (up to 7 days)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Apr 2026
- Study start24 Apr 2023
- Primary completion24 Apr 2028 (estimated)
- Study completion24 Apr 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for RhabdomyolysisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 36 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Tripler Army Medical Center
- Sponsor type
- US federal agency
- Responsible party
- Principal investigator, Chelsea Tagawa, Tripler Army Medical Center
- Investigators
- Chelsea W Tagawa, MD, Principal investigator, Tripler Army Medical Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07528300
- Sponsor's protocol ID
- TAMC 23H29 / 223057
- Status last verified
- Apr 2026
- First submitted
- 15 May 2025
- Last updated
- 14 Apr 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: No plan to be shared.
Study at a glance
From the registry record, last updated by the sponsor on 14 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect of Battlefield Acupuncture on Pain Control During Inpatient Treatment of Exertional Rhabdomyolysis
- ClinicalTrials.gov ID
- NCT07528300
- Acronym / sponsor ID
- TAMC 23H29 / 223057
- Conditions
- Rhabdomyolysis
- Keywords
- battlefield acupuncture, rhabdomyolysis, pain management
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 36 participants (estimated)
- Lead sponsor
- Tripler Army Medical CenterUS federal agency
- Study start
- 24 Apr 2023 (actual)
- Primary completion
- 24 Apr 2028 (estimated)
- Study completion
- 24 Apr 2028 (estimated)
- First posted
- 14 Apr 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Patients admitted with exertional rhabdomyolysis will be offered treatment with battlefield acupuncture for pain management and compared with patient's pain levels and pain medication requirements with those patients who declined battlefield acupuncture.
Detailed description
Pilot study using a prospective observational case series of patients admitted to Tripler Army Medical Center who meet CHAMP criteria for rhabdomyolysis and who elect to undergo BFA in addition to standard of care pain control. We will not blind patients, providers, or research coordinators. Goal is to administer BFA within 12 hours of inpatient admission and monitor the pain response.
Study design
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Battlefield Acupuncture | Active comparator | Procedure: Battlefield AcupuncturePatients admitted with rhabdomyolysis who choose to get battlefield acupuncture for pain control. |
| Patients admitted with rhabdomyolysis who did not receive battlefield acupuncture | No intervention | –This arm is the retrospective group that did not receive the BFA as an intervention. |
Who may qualify
- Ages
- 18 to 99 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- Rhabdomyolysis
- chooses battlefield acupuncture
Key exclusion criteria (4 listed)
- Greater than 72 hours from onset of symptoms
- younger than 18 years of age
- declines battlefield acupuncture
- no pain
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Battlefield AcupunctureTreatment of pain from rhabdomyolysis with battlefield acupuncture | Procedure or surgery | Battlefield Acupuncture |
Primary outcome
Pain Level on a pain scale of 0-10
Time frame: Pain level will be measured through study completion (up to 12 months).
Reported pain levels on a subjective pain score of 0-10
Pain Medication
Time frame: From enrollment to the end of treatment at 12 months
Amount of pain medication required, Morphine equivalent and acetaminophen use on hospital days 1-7
1 secondary outcome
Length of Hospital Stay in days
Time frame: Length of time from admission to discharge in days (up to 7 days)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Apr 2026.
- Individual participant dataSharing planned: No. No plan to be shared.
Related trials for Rhabdomyolysis
RecruitingObservational study
CytOSorb TreatMent Of Critically Ill PatientS Registry
Septic Shock, Acute Respiratory Distress Syndrome
RecruitingObservational study
Impact of Extrarenal Myoglobin Clearance on Renal Recovery in Patients With Severe Rhabdomyolysis
Rhabdomyolysis-Induced Renal Failure
Not yet recruiting
Evaluation of the Effectiveness of Using Virtual Reality Glasses in Prehospital Intervention Training for Crush Syndrome
Rhabdomyolysis, Virtual Reality
RecruitingPhase 1
Dexamethasone Use in Pediatric Rhabdomyolysis Patients in Addition to Standard Protocols
Rhabdomyolysis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Chelsea W Tagawa, MD principal investigator
Tripler Army Medical Center
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Battlefield Acupuncture in people with Rhabdomyolysis, run by Tripler Army Medical Center at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 14 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Chelsea W Tagawa, MD (808-433-2202, chelsea.w.tagawa.civ@health.mil), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Pain Level on a pain scale of 0-10 (time frame: Pain level will be measured through study completion (up to 12 months).). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Apr 2026.